News

Dementia affects more than 6 million Americans and accounts for more than 100,000 deaths each year, with a startling NYU ...
Around 57 million people worldwide have dementia. While most cases of dementia are diagnosed in older adults, about 7% of ...
Many people aren’t benefiting from the shingles vaccine now. Not only can it prevent shingles — it also may protect the brain ...
Having already been hailed for their ability to aid weight loss and treat diabetes, GLP-1 drugs like Ozempic and Mounjaro ...
The simple diet change that could protect against dementia and motor neurone disease - Boosting your consumption of certain ...
Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...
Memory loss is a potential sign of dementia that occurs in progressive stages. Learn about treating and preventing dementia ...
Screens are steadily taking over more and more of our life, leading some researchers to worry about the effect of long-term ...
Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early, but aren't yet reliable for widespread screening, a Karolinska Institutet study finds. A new study published in ...
The authors of an analysis of thousands of medical records across four U.S. communities said Thursday they've found further ...
Both GLP-1 receptor agonists and SGLT2 inhibitors linked to reduced risk for ADRD, with no significant difference between them.
A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...